Company Overview

Aakaar Medical Technologies Limited, originally incorporated as Aakaar Medical Technologies Private Limited on June 20, 2013, was later converted to a public limited company with a fresh certificate of incorporation dated November 18, 2024. The company operates as an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices, dealing in specialty products for dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists.

Aakaar Medical Technologies operates in the medical aesthetics segment, offering a portfolio of aesthetic products and devices through a B2B model. The company's product portfolio encompasses both own brands (domestically manufactured products) and internationally produced devices, as well as imported brands sourced from countries such as South Korea, Spain, Italy, and Austria. The company positions itself as one of the leading aesthetic services providing companies in India with more than 24 years of expertise.

Financial Performance and Market Position

The company has demonstrated robust financial growth, with revenue increasing significantly year-on-year. Profit after tax (PAT) has seen substantial growth, more than doubling in the last fiscal year. EBITDA has also shown a consistent upward trend. While net debt is decreasing, the company maintains a strong financial footing to support its expansion.

Key Financial Metrics

- Revenue from Operations (FY25): ₹61.58 Crores (up 33.5% from FY24)

- Revenue from Operations (FY24): ₹46.11 Crores

- Profit After Tax (PAT) (FY25): ₹6.02 Crores (more than double FY24)

- Profit After Tax (PAT) (FY24): ₹2.87 Crores

- EBITDA (FY25): ₹973.69 Lakhs

- EBITDA (FY24): ₹499.89 Lakhs

- EBITDA (FY23): ₹352.86 Lakhs

- Net Debt (March 2025): ₹11.67 Crores (decreased from ₹14.5 Crores in March 2024)

- Market Capitalization: ₹102.04 Crores (as of March 31, 2025)

- Promoter Holding: 67.00% (as of June 2025)

Business Operations and Product Portfolio

The company operates across multiple product categories and reported a product portfolio of 154 stock-keeping units (SKUs) as of FY25. It sold 5,41,754 units across various segments, including home care, professional care, injectables, contouring products, and medical aesthetic devices. As per recent disclosures, Aakaar Medical Technologies serves 5,000+ medical practitioners and has floated 20,000+ brands (own and imported) with 150+ product SKUs and 37 device SKUs.

The company operates through two primary business segments:

1. Sale of Imported Brands: Involves selling products and devices of reputed aesthetic brands in India via distribution agreements. This segment contributed 70% of the revenue for FY 2024.

2. Sale of Own Brands: Accounted for 30.22% of the company's revenues in Financial Year 2024 and 39.57% for the five-month period ending August 31, 2024.

Aakaar Medical Technologies has partnered with Parekh Integrated Services Pvt. Ltd. (PISPL) as its consignment sales partner, providing access to 21 warehousing centres across India. This partnership ensures wide distribution coverage and helps reduce order-to-delivery timelines. The company has branches across India with a team of 90 trained sales and service engineers, serving thousands of satisfied customers.

Customer Base and Market Reach

As of FY24, Aakaar Medical Technologies serves a customer base of 5,205, comprising doctors and clinic chains across India. The company's customer base is large and dynamic, with new practitioners joining annually. Its top 10 customers contributed 10.96% of the revenue for FY 2024, indicating a low dependency on any single client and a diversified customer mix.

Stock Market Information

- IPO Details:

- Bidding Period: June 20, 2025 – June 24, 2025

- Allotment Finalized: June 25, 2025

- Listing Date: June 27, 2025 (NSE SME)

- IPO Price Band: ₹72 per share

- Current Market Data (as of June 27, 2025):

- PE Ratio: 16.73

- PB Ratio: 0.50

- 52-Week High: ₹75.00

- 52-Week Low: ₹71.25

Market Opportunity and Industry Position

The global medical aesthetics and cosmetic dermatology market was valued at USD 35.9 billion in CY2024 and is projected to reach USD 57.4 billion by CY2030, registering a CAGR of 8.1% during CY2024-CY2030. The Indian medical aesthetics market generated revenue of USD 283.9 million in CY2024 and is expected to grow at a CAGR of 13.9% during the forecasted period.

Aakaar Medical Technologies operates a pure-play B2B business model, supplying exclusively to dermatologists/aesthetic physicians and focusing solely on aesthetic products through medical professionals. The company asserts there are no listed entities of similar size or business model in India that are directly comparable. Major competitors mentioned include Kaya, with a market cap of ₹101 crores, while the median market cap of its peers is ₹561 crores.

The company's strategic focus on the medical aesthetics segment, combined with its extensive distribution network and diversified product portfolio, positions it well to capitalize on the growing demand for aesthetic treatments in India's expanding healthcare market.